Cargando…

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

OBJECTIVE: Faecal microbiota transplantation (FMT) from healthy donors to patients with irritable bowel syndrome (IBS) has been attempted in two previous double-blind, placebo-controlled studies. While one of those studies found improvement of the IBS symptoms, the other found no effect. The present...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Salhy, Magdy, Hatlebakk, Jan Gunnar, Gilja, Odd Helge, Bråthen Kristoffersen, Anja, Hausken, Trygve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Gut Microbiota
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229896/ https://www.ncbi.nlm.nih.gov/pubmed/31852769 http://dx.doi.org/10.1136/gutjnl-2019-319630

Ejemplares similares

Stomach antral endocrine cells in patients with irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2014)

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review)
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population
por: Hugerth, Luisa W, et al.
Publicado: (2020)

Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders
por: Sbahi, Hani, et al.
Publicado: (2016)

Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
por: Zuo, Tao, et al.
Publicado: (2018)

Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
por: de Groot, Pieter, et al.
Publicado: (2021)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
por: El-Salhy, Magdy, et al.
Publicado: (2019)

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer
por: Liang, Jessie Qiaoyi, et al.
Publicado: (2020)

Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)
por: Ng, Siew C, et al.
Publicado: (2020)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
por: El-Salhy, Magdy, et al.
Publicado: (2019)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma
por: Chen, Feng, et al.
Publicado: (2022)

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery
por: Jalanka, Jonna, et al.
Publicado: (2023)

Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study
por: Koopen, Annefleur, et al.
Publicado: (2022)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Density of Musashi-1-positive stem cells in the stomach of patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

The oral microbiota in colorectal cancer is distinctive and predictive
por: Flemer, Burkhardt, et al.
Publicado: (2018)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

Microbiota-induced obesity requires farnesoid X receptor
por: Parséus, Ava, et al.
Publicado: (2017)

Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus
por: Wang, Jinfeng, et al.
Publicado: (2018)

Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer
por: Coker, Olabisi Oluwabukola, et al.
Publicado: (2019)

Tumour-associated and non-tumour-associated microbiota in colorectal cancer
por: Flemer, Burkhardt, et al.
Publicado: (2017)

Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet
por: Manichanh, Chaysavanh, et al.
Publicado: (2014)

Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers
por: Lavelle, A, et al.
Publicado: (2015)

Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention
por: Hibberd, Ashley A, et al.
Publicado: (2017)

Gut microbiota in hypertensive patients with versus without obstructive sleep apnea
por: Lu, Dasheng, et al.
Publicado: (2022)

Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis
por: Pinto, Yishay, et al.
Publicado: (2023)

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
por: Pérez-Cobas, Ana Elena, et al.
Publicado: (2013)

Prebiotic inulin-type fructans induce specific changes in the human gut microbiota
por: Vandeputte, Doris, et al.
Publicado: (2017)

Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota
por: Tito, Raul Y, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7taoe1s5ebdjvnffrsjnen3ja0